Primecap Management CO Fibrogen Inc Transaction History

Primecap Management CO

$134 Billion
Q3 2024

A detailed history of Primecap Management CO transactions in Fibrogen Inc stock. As of the latest transaction made, Primecap Management CO holds 9,911,231 shares of FGEN stock, worth $3.47 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,911,231

Previous 13,655,948 27.42%

Holding current value

$3.47 Million

Previous $12.2 Million 67.38%

% of portfolio

0.0%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$0.33 - $1.26 $1.24 Million - $4.72 Million	-3,744,717 Reduced 27.42%	9,911,231 $3.96 Million
Q2 2024 Aug 09, 2024	SELL	$0.89 - $2.36 $681,036 - $1.81 Million	-765,210 Reduced 5.31%	13,655,948 $12.2 Million
Q1 2024 May 13, 2024	SELL	$0.73 - $2.73 $37,062 - $138,602	-50,770 Reduced 0.35%	14,421,158 $33.9 Million
Q4 2023 Feb 09, 2024	SELL	$0.38 - $0.91 $96,155 - $230,266	-253,040 Reduced 1.72%	14,471,928 $12.9 Million
Q3 2023 Nov 13, 2023	BUY	$0.79 - $2.83 $827,430 - $2.96 Million	1,047,380 Added 7.66%	14,724,968 $12.7 Million
Q2 2023 Aug 11, 2023	SELL	$2.49 - $20.59 $1.12 Million - $9.25 Million	-449,109 Reduced 3.18%	13,677,588 $36.9 Million
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $3.69 Million - $5.83 Million	231,619 Added 1.67%	14,126,697 $264 Million
Q4 2022 Feb 13, 2023	BUY	$13.27 - $17.73 $9.49 Million - $12.7 Million	715,181 Added 5.43%	13,895,078 $223 Million
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $256,158 - $328,062	-22,470 Reduced 0.17%	13,179,897 $171 Million
Q2 2022 Aug 11, 2022	SELL	$7.94 - $12.96 $916,990 - $1.5 Million	-115,490 Reduced 0.87%	13,202,367 $139 Million
Q1 2022 May 11, 2022	BUY	$12.02 - $16.79 $3.95 Million - $5.52 Million	328,734 Added 2.53%	13,317,857 $160 Million
Q4 2021 Feb 11, 2022	BUY	$9.93 - $15.39 $1.96 Million - $3.04 Million	197,366 Added 1.54%	12,989,123 $183 Million
Q3 2021 Nov 12, 2021	BUY	$10.18 - $26.64 $2.53 Million - $6.61 Million	248,209 Added 1.98%	12,791,757 $131 Million
Q2 2021 Aug 10, 2021	BUY	$18.57 - $35.68 $14.3 Million - $27.5 Million	771,790 Added 6.56%	12,543,548 $334 Million
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $78.9 Million - $142 Million	2,543,738 Added 27.57%	11,771,758 $409 Million
Q4 2020 Feb 08, 2021	BUY	$37.09 - $48.97 $79.5 Million - $105 Million	2,143,987 Added 30.27%	9,228,020 $342 Million
Q3 2020 Nov 13, 2020	BUY	$40.47 - $45.5 $64.8 Million - $72.9 Million	1,602,150 Added 29.23%	7,084,033 $291 Million
Q2 2020 Aug 13, 2020	BUY	$32.57 - $42.83 $15 Million - $19.7 Million	459,350 Added 9.15%	5,481,883 $222 Million
Q1 2020 May 14, 2020	BUY	$23.3 - $45.96 $92.7 Million - $183 Million	3,979,159 Added 381.37%	5,022,533 $175 Million
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $36.1 Million - $50.1 Million	1,043,374 New	1,043,374 $44.8 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Fibrogen Inc Transaction History